According to filings with the U.S. Securities and Exchange Commission, Calyxo is raising $50,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joe Catanese played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Calyxo
Calyxo, Inc. was founded in February 2016 in collaboration with leading U.S. urologists who recognized the profound need for improved kidney stone treatment. Kidney stone disease is a common problem that is painful and consumes vast amounts of healthcare resources each year. We are focused on delivering innovative solutions to better meet the needs of kidney stone patients and transform the care of this condition. We are dedicated to improving care for patients with kidney stones by delivering paradigm-shifting solutions that enable urologists to safely, effectively and efficiently achieve unrivaled clinical outcomes. We envision a day when kidney stones are efficiently removed in a routine, one-time treatment, leaving behind only peace of mind for both patients and physicians.

To learn more about Calyxo, visit http://calyxoinc.com/

Contact:
Joe Catanese, Chief Executive Officer
925-526-5900

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.